Glucose Health Price to Free Cash Flow Ratio 2014-2019 | GLUC

Glucose Health price to free cash flow ratio from 2014 to 2019. Price to free cash flow ratio can be defined as

Glucose Health Price to Free Cash Flow Ratio 2014-2019 | GLUC

Glucose Health price to free cash flow ratio from 2014 to 2019. Price to free cash flow ratio can be defined as
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$206.3B
Stryker (SYK)$148B
Boston Scientific (BSX)$133.7B
EssilorLuxottica (ESLOY)$111.2B
Medtronic (MDT)$110.6B
Haleon (HLN)$44B
Lonza Group Ag (LZAGY)$42.2B
GE HealthCare Technologies (GEHC)$37.9B
ResMed (RMD)$36.6B
Terumo (TRUMY)$30.3B
Koninklijke Philips (PHG)$25.5B
Zimmer Biomet Holdings (ZBH)$22.3B
Insulet (PODD)$18.7B
Baxter (BAX)$17B
Smith & Nephew SNATS (SNN)$11.2B
BellRing Brands (BRBR)$9.9B
Bio-Rad Laboratories (BIO)$9.5B
Demant (WILYY)$8.3B
Lantheus Holdings (LNTH)$6.3B
TG Therapeutics (TGTX)$5.4B
Haemonetics (HAE)$4.4B
Prestige Consumer Healthcare (PBH)$4.2B
Perrigo (PRGO)$3.9B
ICU Medical (ICUI)$3.9B
Envista Holdings (NVST)$3.8B
Agios Pharmaceuticals (AGIO)$3.3B
Neogen (NEOG)$3.1B
Shandong Weigao Medical Polymer (SHWGF)$3B
GN Store Nord (GNNDY)$2.9B
QuidelOrtho (QDEL)$2.8B